Latest / Real Life Pharmacology - Pharmacology Education for Health Care Professionals
Pimavanserin Pharmacology Podcast
Pimavanserin is an atypical antipsychotic approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Unlike traditional antipsychotics, it does not block dopamine receptors, making it a unique option for patients with Parkinson’s disease who are highly sensitive to dopamine antagonism.
Mechanism of Action
Pimavanserin works primarily as a selective serotonin 5-HT2A inverse agonist and antagonist, with minor activity at 5-HT2C receptors. This dopamine-sparing effect is the key reason it does not worsen motor symptoms in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.